Iodine status of young Burkinabe children receiving small-quantity lipid-based nutrient supplements and iodised salt:

Sonja Y Hess1, Souheila Abbeddou1, Elizabeth Yakes Jimenez2

  • 11Program in International and Community Nutrition,Department of Nutrition,University of California Davis,Davis,CA 95616,USA.

Insights

Small-quantity lipid-based nutrient supplements (SQ-LNS) did not significantly alter iodine status in young children already consuming iodized salt. Reducing iodine in SQ-LNS may be feasible where salt iodization is effective.

Area of Science:

  • Nutrition Science
  • Public Health
  • Pediatrics

Background:

  • Iodine deficiency remains a global public health concern, impacting cognitive development in children.
  • Effective salt iodization programs are crucial for ensuring adequate iodine intake.
  • The role of nutrient supplements in iodine status requires further investigation, especially in populations with existing salt iodization.

Purpose of the Study:

  • To evaluate the impact of small-quantity lipid-based nutrient supplements (SQ-LNS) containing iodine on the iodine status of young children in Burkina Faso.
  • To assess the influence of SQ-LNS on thyroid function markers, including urinary iodine (UI), thyroid-stimulating hormone (TSH), thyroxine (T4), and thyroglobulin (Tg).

Main Methods:

  • A community-based intervention study involving 34 communities in Burkina Faso, divided into intervention (IC) and non-intervention cohorts (NIC).
  • IC children received daily SQ-LNS with varying iodine and zinc content from 9 to 18 months of age.
  • NIC children did not receive SQ-LNS but had access to iodized salt through a national program. Biomarkers were measured at 9 and 18 months.

Main Results:

  • No significant differences in UI, TSH, or T4 were observed between the IC and NIC groups at 18 months.
  • Plasma thyroglobulin (Tg) was initially higher in NIC but normalized by 18 months.
  • All children exhibited adequate iodine status (UI > 339 µg/l) and normal TSH levels at 18 months, with only a marginal increase in low T4 in the NIC group.

Conclusions:

  • In settings with effective salt iodization, SQ-LNS may not be necessary for improving iodine status in young children.
  • The iodine content in SQ-LNS could potentially be reduced without compromising iodine status, offering cost-saving opportunities.
  • Continued monitoring of iodine status is essential, even with widespread salt iodization programs.

Related Concept Videos

Redox Titration: Iodimetry and Iodometry01:23

Redox Titration: Iodimetry and Iodometry

Iodometry and iodimetry are analytical methods used to determine the concentration of oxidizing or reducing agents using iodine. In iodometric titrations, the oxidizing analyte solution is usually acidified and treated with an excess of iodide ions, which generates an equivalent amount of iodine in equilibrium with triiodide. The released iodine is subsequently titrated directly against a standardized reducing agent. As the dilute iodine color becomes pale yellow, a few drops of freshly...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...